Overview
Nandini Ignatius is a Hematologist Oncology provider in Robbinsville, New Jersey. Dr. Ignatius is rated as an Experienced provider by MediFind in the treatment of Drug-Induced Thrombocytopenia. Her top areas of expertise are Iron Deficiency Anemia, Thrombocytopenia, Deep Vein Thrombosis, and Drug-Induced Thrombocytopenia.
Her clinical research consists of co-authoring 1 peer reviewed article and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1 Washington Boulevard, Suite 9, Robbinsville, NJ 8691.
9 Centre Drive, Suite 100, Monroe Township, NJ 8831.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Minerva D. Braemer Medical Arts Building
Felice Lepar is a Hematologist and an Oncologist in East Norriton, Pennsylvania. Dr. Lepar is rated as a Distinguished provider by MediFind in the treatment of Drug-Induced Thrombocytopenia. Her top areas of expertise are Drug-Induced Thrombocytopenia, Iron Deficiency Anemia, Thrombocytopenia, and Childhood Iron Deficiency Anemia. Dr. Lepar is currently accepting new patients.
Temple Faculty Practice Plan Inc
Michael Seidman is a Hematologist Oncology specialist and an Oncologist in Philadelphia, Pennsylvania. Dr. Seidman is rated as a Distinguished provider by MediFind in the treatment of Drug-Induced Thrombocytopenia. His top areas of expertise are Drug-Induced Thrombocytopenia, Paget Disease of the Breast, Breast Cancer, and Iron Deficiency Anemia.
Jessica Berman is a Hematologist Oncology specialist and a Hematologist in Meadowbrook, Pennsylvania. Dr. Berman is rated as a Distinguished provider by MediFind in the treatment of Drug-Induced Thrombocytopenia. Her top areas of expertise are Drug-Induced Thrombocytopenia, Familial Colorectal Cancer, Hemochromatosis, and Childhood Iron Deficiency Anemia.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Mountain SicknessDr. Ignatius isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with MaturationDr. Ignatius isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Ignatius isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Ignatius isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Ignatius isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.